‘A slow-moving glacier’: NIH’s sluggish and often opaque efforts to study long Covid draw patient, expert ire

Critics charge that, in addition to being slow to recruit patients, the NIH's long Covid initiative is looking at open-ended research questions rather than testing out therapies or treatments.

WASHINGTON — The National Institutes of Health is fumbling its first efforts to study long Covid.

Fifteen months ago, Congress showered the agency with a massive $1.2 billion to research the mysterious cases of patients who never fully recover from Covid-19 infections. But so far the NIH has brought in just 3% of the patients it plans to recruit.

Read the rest…